IL-18 is present in the serum of CD patients, and bioactive IL-18 expression along with IL-18-induced cytokines are increased in mucosal biopsies of patients with IBD compared to controls, in involved vs. non-involved lesions, and in chronic advanced compared to early asymptomatic disease (14, 15, 91). Here, IL18 is linked to inflammatory bowel disease.